Baseline characteristics | Female n = 15 | Male n = 116 | Total group n = 131 |
---|---|---|---|
Age (years) | 65 (58, 68) | 67 (56, 72) | 66 (56, 72) |
BMI (kg/m2) | 30.5 (28.0, 35.1)* | 26.8 (24.5, 30.0) | 27.1 (24.8, 30.8) |
EuroSCORE II, | 1.7 (1.3, 2.4) | 1.5 (1.1, 2.2) | 1.5 (1.1, 2.2) |
Diabetes mellitus | 4 (27%) | 26 (22%) | 30 (23%) |
Pulmonary disease | 3 (20%) | 11 (10%) | 14 (11%) |
Arterial vascular disease | 0 (0%) | 7 (6%) | 7 (5%) |
Renal disease | 1 (7%) | 12 (10%) | 13 (10%) |
LVEF | |||
> 50% | 0 (0%) | 1 (1%) | 1 (1%) |
30–50% | 4 (27%) | 35 (30%) | 39 (30%) |
< 30% | 11 (73%) | 80 (69%) | 91 (70%) |
Preoperative sarcopenia parameters | |||
Grip strength (N/kg) | 2.4 ± 0.6* | 4.9 ± 1.1 | 4.6 ± 1.3 |
ASMM (kg) | 22.2 (20.2, 22.8)* | 26.0 (23.8, 28.2)1 | 25.6 (22.9, 28.0) |
ASMM (kg/m2) | 7.5 (7.2, 7.9)* | 8.1 (7.4, 8.7)1 | 7.9 (7.4, 8.6) |
Phase angle | 6.2 ± 1.1 | 6.6 ± 0.91 | 6.6 ± 0.9 |
Resistance | 470.3 ± 35.0* | 430.2 ± 63.51 | 434.9 ± 62.1 |
Reactance | 50.7 ± 9.5 | 49.6 ± 7.51 | 49.7 ± 7.7 |
Preoperative Health-related quality of life | |||
PCS baseline2,3 | 51.1 (37.9, 61.8)* | 65.6 (52.8, 81.2) | 63.7 (50.1, 78.1) |
MCS baseline2,4 | 61.9 (51.6, 71.8)* | 76.8 (61.3, 90.1) | 73.8 (60.1, 87.8) |
PCS 6 months | 68.1 (59.4, 92.5) | 75.0 (60.9, 87.5) | 74.9 (60.3, 88.4) |
MCS 6 months | 73.4 (50.2, 88.1) | 80.3 (64.6, 88.9) | 79.4 (64.5, 88.4) |